First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

Lignende værker

• Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach
  af: Brussee, Janneke M., et al.
  Udgivet: (2018)
• A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children
  af: Brussee, Janneke M., et al.
  Udgivet: (2019)
• The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery
  af: Brill, Margreke J., et al.
  Udgivet: (2015)
• Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure
  af: Brussee, Janneke M., et al.
  Udgivet: (2017)
• Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1‐OH‐midazolam in morbidly obese and weight loss surgery patients
  af: Brill, MJE, et al.
  Udgivet: (2015)